, Enjeux scientifiques, éthiques et sociétaux. l'Actualité Chimique, vol.407, p.6, 2016.
Epigenetic protein families: A new frontier for drug discovery, Nat. Rev. Drug Discov, vol.11, 2012. ,
Vorinostat: A new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma, Expert. Opin. Investig. Drugs, vol.16, 1111. ,
Romidepsin: A new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors, Expert Rev. Anticancer Ther, vol.10, 2010. ,
Belinostat: First Global Approval, Drugs, vol.74, p.1543, 2014. ,
Approves New Agent for Multiple Myeloma, J. Natl. Cancer Inst, vol.107, 2015. ,
Interpreting clinical assays for histone deacetylase inhibitors, Cancer Manag. Res, vol.3, pp.117-141, 2011. ,
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity, Adv. Drug Deliv. Rev, vol.91, 2015. ,
Characterization of vascular permeability-increasing component isolated from solid tumors and the effect of highly polymerized dextran sulfate on its activity, Jpn. J. Pharmacol, vol.41, pp.163-171, 1986. ,
Self-assembled aptamer-grafted hyperbranched polymer nanocarrier for targeted and photoresponsive drug delivery, Ang. Chem. Int. Ed, 2018. ,
Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-lactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine, J. Pharm. Sci, vol.101, pp.3787-3798, 2012. ,
, Biomolecules, vol.9, pp.60-73, 2019.
Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells, Pharm. Res, vol.31, 1978. ,
Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer, Biomed. Pharmacother, vol.68, pp.865-871, 2014. ,
Nanostructured delivery system for Suberoylanilide hydroxamic acid against lung cancer cells, Mater. Sci. Eng. C. Mater. Biol. Appl, vol.51, pp.362-368, 2015. ,
Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors, Biomaterials, vol.51, pp.208-215, 2015. ,
Development of lipid nanoparticles for a histone deacetylases inhibitor as a promising anticancer therapeutic, Drug Deliv, vol.2015, pp.1-9 ,
Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: An in vitro investigation on human breast cancer and leukemia cell lines, J. Pharm. Pharm. Sci, vol.17, pp.231-247, 2014. ,
Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells, Carbohydr. Polym, vol.114, pp.407-415, 2014. ,
Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer, Biomaterials, vol.67, pp.183-193, 2015. ,
Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer, Nanomedicine, vol.9, pp.1124-1134, 2013. ,
Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells, J. Nanobiotechnol, vol.13, 2015. ,
Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo, Nanomedicine, vol.12, pp.43-58, 2017. ,
A facile route to form self-carried redox-responsive vorinostat nanodrug for effective solid tumor therapy, Int. J. Nanomed, vol.11, pp.6003-6022, 2016. ,
Nanovecteurs ou particules polymères et leur utilisation comme médicament et/ou agent de diagnostic, 2013. ,
Design of pH responsive clickable prodrugs applied to histone deacetylases inhibitors: A new strategy for anticancer therapy, Eur. J. Pharm. Biopharm, vol.85, pp.862-872, 2013. ,
Triazolyl Derivatives for Acidic Release of Alcohols, Eur. J. Org. Chem, vol.11, pp.2111-2119, 2011. ,
Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy, vol.6, pp.795-807, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01299450
Nanoparticles produced by ring-opening metathesis polymerization using norbornenyl-poly(ethylene oxide) as a ligand-free generic platform for highly selective in vivo tumor targeting, Biomacromolecules, vol.14, pp.239-2402, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00931576
, Biomolecules, vol.9, pp.60-74, 2019.
An easy and effective method to produce functionalized particles for cellular uptake, J. Polym. Sci. Part A Polym. Chem, vol.51, pp.176-189, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00918361
Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds. Curr. Cancer Drug Targets, vol.11, pp.919-928, 2011. ,
Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug delivery, Eur. J. Med. Chem, vol.95, pp.369-376, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01368838
Vorinostat-polymer conjugate nanoparticles for Acid-responsive delivery and passive tumor targeting, Biomacromolecules, vol.15, pp.4534-4543, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01369441
New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells, Oncotarget, vol.5, pp.4504-4515, 2014. ,
A 5-aza-2-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma, Eur. Respir. J, vol.38, pp.1105-1116, 2011. ,
Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression, J. Med. Chem, vol.52, pp.3112-3115, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00438795
Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers, Nanomedicine, vol.13, pp.885-896, 2017. ,
Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis, Characterization, Biodegradation, and Anticancer Activity, AAPS PharmSciTech, vol.19, pp.634-647, 2018. ,
Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy, Oncotarget, vol.8, pp.14925-14940, 2017. ,
Supramolecular cisplatin-vorinostat nanodrug for overcoming drug resistance in cancer synergistic therapy, J. Control. Release, vol.266, pp.36-46, 2017. ,